Delivery Order SPE2DB24D2106-SPE2DB25FAVYK
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $4,947.96 firm fixed-price delivery order by the Defense Logistics Agency on August 14, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine. The contract, which carries an ultimate completion date of August 15, 2025, was issued without a set-aside designation. Performance will take place in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $94,236.00 to DMS Pharmaceutical Group Inc. on June 18, 2025, for the supply of Menveo 1 vial (meningococcal vaccine, groups A, C, Y, and W-135) in 0.5mL dosage form. This firm fixed-price delivery order, with an ultimate completion date of June 20, 2025, was issued without a set-aside designation. The order will be fulfilled from DMS Pharmaceutical Group's location in Park Ridge, Illinois, and represents a component of the...
- The Defense Logistics Agency awarded a delivery order valued at $1,801.55 to DMS Pharmaceutical Group Inc. for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal vaccine product. This firm fixed-price delivery order, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, was executed without a set-aside designation. The award represents a standard transactional order under DMS Pharmaceutical Group's broader pharmaceutical supply contract with DLA, fulfilling the...
- The Defense Logistics Agency awarded a $8,647.44 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MENVEO A-C-Y-W Kit (2 Vials). The award was issued on May 8, 2025, with an ultimate completion date of May 9, 2025, and does not include any set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,441.24 by the Defense Logistics Agency on July 30, 2025. The delivery order is for MENVEO A-C-Y-W Kit (2 Vials), a meningococcal vaccine product, with an ultimate completion date of July 31, 2025. This award carries no set-aside designation, allowing the vendor to compete on an unrestricted basis in the federal...
- This delivery order awards $2,075.82 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL vaccine product. The Defense Logistics Agency issued this firm fixed-price delivery order on July 25, 2025, with an ultimate completion date of July 28, 2025. The award carries no set-aside designation, and performance will occur at the contractor's Park Ridge, Illinois location. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,535.52 to DMS Pharmaceutical Group Inc. for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. The contract, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, operates under firm fixed-price terms with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the...
- Defense Logistics Agency Troop Support Medical has awarded DMS Pharmaceutical Group Inc. a $6,236.64 firm fixed price delivery order to supply one vial of MENVEO, a meningococcal vaccine. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with Defense Logistics Agency to provide various pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. No set-aside designation was used for this award. DMS...
- This $27,477.72 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccines, with an ultimate completion date of August 7, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $12,676.34, is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of May 8, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- SPE2DB24D2106Indefinite Delivery Contract
- SPE2DB24D2106-SPE2DB25FAVYKDelivery Order
The Defense Logistics Agency awarded a $2,195.46 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on August 8, 2025, with an ultimate completion date of August 11, 2025. The delivery order covers Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL, a meningococcal conjugate vaccine, to be delivered to Conshohocken, Pennsylvania. This award carries no set-aside designation and represents a discrete delivery order issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026. DMS Pharmaceutical Group, based in Park Ridge, Illinois, has established itself as a critical supplier within the federal pharmaceutical supply chain since its SAM.gov registration in 2001. The company specializes in distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. Through its DLA IDC, the vendor regularly fulfills delivery orders for an extensive portfolio of pharmaceutical products, including vaccines and injections like the Menveo vaccine covered under this award, enabling the agency to maintain consistent medical supply support for military health facilities globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/8/25 |